Each year thousands of patients face life-long losses in sensation and motor function from spinal cord injury and related conditions in which axons are badly damaged or severed. New research in mice shows, however, that gains in functional recovery from these injuries may be possible, thanks to a molecule known as Lin28, which regulates cell […]
As the internet churns with information about Covid-19, about the virus that causes the disease, and about what we’re supposed to do to fight it, it can be difficult to see the forest for the trees. What can we realistically expect for the rest of 2020? And how do we even know what’s realistic? Today, […]
As epidemiologists attempt to scope out what Covid-19 has in store for the U.S. this summer and beyond, they see several potential futures, differing by how often and how severely the no-longer-new coronavirus continues to wallop humankind. But while these scenarios diverge on key details — how much transmission will decrease over the summer, for instance, […]
Giant elliptical galaxies are not as likely as disk-shaped galaxies, such as our own Milky Way, to be cradles of technological civilizations, according to a recent article by a astrophysicist.
Years of my cancer research work came to a grinding halt on March 13. I certainly wasn’t alone. Researchers across the country had to shutter their labs when universities suspended research that was considered “non-essential” to follow social distancing and help slow the spread of Covid-19. Part of “pausing” my research meant stopping all enrollment […]
Most countries are at a standstill, with social distancing and physical distancing measures in place to reduce the spread of the novel coronavirus. Now, a new transmission model of the coronavirus disease (COVID-19) confirms that social distancing measures were effective in Wuhan City, the epicenter of the coronavirus pandemic, and Shanghai in China.
-Enrollment ongoing in clinical trials of CTX001™ for patients with severe hemoglobinopathies- -Enrollment ongoing in clinical trial of CTX110 ™ , targeting CD19+ malignancies- -Began treating patients in clinical trial of CTX120™, targeting B-cell maturation antigen (BCMA)- -IND and CTA approved